1992
Prevalence of Tuberculin Positivity and Skin Test Anergy in HIV-1—Seropositive and —Seronegative Intravenous Drug Users
Graham N, Nelson K, Solomon L, Bonds M, Rizzo R, Scavotto J, Astemborski J, Vlahov D. Prevalence of Tuberculin Positivity and Skin Test Anergy in HIV-1—Seropositive and —Seronegative Intravenous Drug Users. JAMA 1992, 267: 369-373. PMID: 1727959, DOI: 10.1001/jama.1992.03480030047035.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seropositivesSkin test anergyHIV-1 seropositive groupSeronegative intravenous drug usersTuberculin positivityLymphocyte countPPD positivityHIV-1-seropositive intravenous drug usersPPD tuberculinDrug usersHuman immunodeficiency virus serostatusSeropositive intravenous drug usersHIV-1 seropositive patientsTuberculin skin test resultsHIV-1 seronegativeHIV-1 seronegativesPPD test resultsHIV-1 seropositivityDelayed-type hypersensitivityCommunity-based cohortSkin test resultsYears of agePositive test resultsInverse linear trend
1986
Candidal Suppurative Peripheral Thrombophlebitis Recognition, Prevention, and Management
Walsh T, Bustamente C, Vlahov D, Standiford H. Candidal Suppurative Peripheral Thrombophlebitis Recognition, Prevention, and Management. Infection Control And Hospital Epidemiology 1986, 7: 16-22. PMID: 3633240, DOI: 10.1017/s0195941700063736.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmphotericin BCandidiasisCatheterizationHumansMaleMiddle AgedSuppurationThrombophlebitisConceptsPeripheral thrombophlebitisBroad-spectrum antibiotic therapyCatheter site careSegmental venous resectionIntravenous amphotericin BDuration of hospitalizationCandida speciesAcute care hospitalsNosocomial fungal infectionsSuppurative thrombophlebitisVenous resectionCatheter siteAntibiotic therapyPalpable cordRisk factorsSite careCandidal colonizationRational therapyPatientsAmphotericin BBacterial infectionsThrombophlebitisFungal infectionsTherapyInfection